A recent businesswire article discussed the latest product to receive the FDA’s coveted emergency use authorization. The Detect COVID-19 test from Detect™, Inc. will be available for over-the-counter home use in the coming weeks. The cost will be under $50, which makes it the lowest priced at-home molecular test available to consumers. The test will also be used for regular screening programs in school and workplaces.
OTC COVID-19 Test Gets FDA Emergency Use Authorization
The DETECT™ test will be the lowest priced PCR-quality test available for use at home.
Nov 5, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
